Evidence map›Paper›PMID 29940972›Full record

ArticleJournal of translational medicine2018

Triglyceride profiling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals.

Haya Al-Sulaiti, Ilhame Diboun, Sameem Banu, Mohamed Al-Emadi, Parvaneh Amani, Thomas M Harvey, Alex S Dömling, Aishah Latiff, Mohamed A Elrayess

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. The Circulating Lipidome In Severe Obesity.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Metabolomic signatures of low- and high-adiposity neonates differ based on maternal BMI.American journal of physiology. Endocrinology and metabolism · 2022
    Article
  18. Metabolic risk factors of ovarian cancer: a review.JBRA assisted reproduction · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Haya Al-SulaitiToxicology and Multipurpose Lab, Anti Doping Laboratory Qatar, Sports City, Doha, Qatar.
Ilhame DibounDepartment of Economics, Mathematics and Statistics, Birkbeck, University of London, London, WC1E 7HX, UK.
Sameem BanuToxicology and Multipurpose Lab, Anti Doping Laboratory Qatar, Sports City, Doha, Qatar.
Mohamed Al-EmadiGeneral Surgery Department, Al-Emdi Hospital, Doha, Qatar.
Parvaneh AmaniGeneral Surgery Department, Al-Emdi Hospital, Doha, Qatar.
Thomas M HarveyToxicology and Multipurpose Lab, Anti Doping Laboratory Qatar, Sports City, Doha, Qatar.
Alex S DömlingDepartment of Drug Design, University of Groningen, A. Deusinglaan 1, 9713 AV, Groningen, Netherlands.
Aishah LatiffToxicology and Multipurpose Lab, Anti Doping Laboratory Qatar, Sports City, Doha, Qatar.
Mohamed A ElrayessToxicology and Multipurpose Lab, Anti Doping Laboratory Qatar, Sports City, Doha, Qatar. melrayess@adlqatar.qa.ORCID 0000-0003-3803-4604
Anti-Doping Laboratory · QAAl Emadi Hospital · QABirkbeck, University of London · GBThe Royal Free Hospital · GBUniversity of Groningen · NL

Funding

Qatar National Research Fund NPRP6-235-1-048
6 · The paper itself

Abstract

backgroundLipid intermediates produced during triacylglycerols (TAGs) synthesis and lipolysis in adipocytes interfere with the intracellular insulin signaling pathway and development of insulin resistance. This study aims to compare TAG species and their fatty acid composition in adipose tissues from insulin sensitive (IS), insulin resistant (IR) and type 2 diabetes mellitus (T2DM) obese individuals.

methodsHuman subcutaneous and omental adipose tissue biopsies were obtained from 64 clinically characterized obese individuals during weight reduction surgery. TAGs were extracted from the adipose tissues using the Bligh and Dyer method, then were subjected to non-aqueous reverse phase ultra-high performance liquid chromatography and full scan mass spectrometry acquisition and data dependent MS/MS on LTQ dual cell linear ion trap. TAGs and their fatty acid contents were identified and compared between IS, IR and T2DM individuals and their levels were correlated with metabolic traits of participants and the adipogenic potential of preadipocyte cultures established from their adipose tissues.

resultsData revealed 76 unique TAG species in adipose tissues identified based on their exact mass. Analysis of TAG levels revealed a number of TAGs that were significantly altered with disease progression including C46:4, C48:5, C48:4, C38:1, C50:3, C40:2, C56:3, C56:4, C56:7 and C58:7. Enrichment analysis revealed C12:0 fatty acid to be associated with TAGs least abundant in T2DM whereas C18:3 was found in both depleted and enriched TAGs in T2DM. Significant correlations of various adipose tissue-derived TAG species and metabolic traits were observed, including age and body mass index, systemic total cholesterol, TAGs, and interleukin-6 in addition to adipogenic potential of preadipocytes derived from the same adipose tissues.

conclusionPilot data suggest that adipose tissues from obese IR and T2DM individuals exhibit TAG-specific signatures that may contribute to their increased risk compared to their IS counterparts. Future experiments are warranted to investigate the functional relevance of these specific lipidomic profiles.

Indexed as

Insulin ResistanceAdipose TissueAdultDiabetes Mellitus, Type 2Discriminant AnalysisFatty AcidsFemaleHumansLeast-Squares AnalysisMaleMolecular WeightObesityOmentumSubcutaneous FatTriglyceridesFatty AcidsTriglyceridesAdipose tissueInsulin resistanceInsulin sensitivityLipidomicsTriaclyglycerolsType 2 diabetes mellitus

Identifiers

PMID29940972
PMCPMC6019324
OpenAlexW2810121433

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.